Expanded Use of Immunotherapy Could Benefit Patients with Cervical Cancer
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of...
Tag: Pembrolizumab
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of...
A short time after Mallika Lala, PhD, finished her presentation titled “Pembrolizumab 400 mg Q6W dosing: First clinical outcomes...
The use of immunotherapy in the treatment of cancer has dramatically increased in the five years since the U.S....
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...
The U.S. Food and Drug Administration (FDA) has approved expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include...
On the heels of the U.S. Food and Drug Administration’s approval of a combination of immune checkpoint inhibitors for...
This year, at the AACR Annual Meeting held in Philadelphia April 18 to 22, an astounding 19,300 members of...
Immunotherapeutics called PD-1 inhibitors have garnered a lot of attention in the past year thanks to exciting clinical trial...
After making great strides for some patients with melanoma and lung cancer, immunotherapy drugs are starting to offer hope...